Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisPatricia Cortazar, Gϋnter von Minckwitz, Hervé Bonnefoi et al.|The Lancet|2014Cited by 4.7k
False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapyJana de Boniface, Steffi Hartmann, Jan Frisell et al.|Breast Cancer Research and Treatment|2022Cited by 31
Meetings and Conferences · Tagungen und KongresseKoji Kawakami, Wen Yun, Gϋnter von Minckwitz et al.|Breast Care|2013Cited by 0